Stock Earnings

Question 1

How did DNLI's recent EPS compare to expectations?

Accepted Answer

The most recent EPS for Denali Therapeutics Inc is $-0.74, not beating expectations of $-0.76.

Question 2

How did Denali Therapeutics Inc DNLI's revenue perform in the last quarter?

Accepted Answer

Denali Therapeutics Inc revenue for the last quarter is $-0.74

Question 3

What is the revenue estimate for Denali Therapeutics Inc?

Accepted Answer

According to 18 of Wall street analyst, the revenue estimate of Denali Therapeutics Inc range from $15.75M to $0.0

Question 4

What's the earning quality score for Denali Therapeutics Inc?

Accepted Answer

Denali Therapeutics Inc has a earning quality score of B+/52.445015. The score is based on a four dimension of Profitability, Growth, Cash generation & Capital Allocation, and Leverage.

Question 5

When does Denali Therapeutics Inc report earnings?

Accepted Answer

Denali Therapeutics Inc next earnings report is expected in 2026-02-04

Question 6

What are Denali Therapeutics Inc's expected earnings?

Accepted Answer

Denali Therapeutics Inc expected earnings is $0.0, according to wall-street analysts.

Question 7

Did Denali Therapeutics Inc beat earnings expectations?

Accepted Answer

Denali Therapeutics Inc recent earnings of $0.0 does not beat expectations.

Fiscal Period	Estimated	Reported	Surprise	Result
Q3 '25	$-0.76	$-0.74	-2.63%	MISSED
Q2 '25	$-0.73	$-0.72	-1.36%	MISSED
Q1 '25	$-0.7	$-0.78	+11.42%	BEAT
Q4 '24	$-0.81	$-0.67	-17.28%	MISSED
Q3 '24	$-0.62	$-0.63	+1.61%	BEAT

Denali Therapeutics Inc (DNLI) Price

DNLI Stock Price Chart

Latest Earnings Results: Q3 '25

Historical Earnings

Earnings FAQ